1. The definition of classification of dry eye diseases: report of the Definition and Classification Subcommittee of the Internationanl Dry Eye WorkShop (2007). Ocul Surf. 2007; 5:75–92.
2. Raphael M, Bellefqih S, Piette JC, et al. Conjunctival biopsy in Sjögren's syndrome: correlations between histological and immunohistochemiscal features. Histopathology. 1988; 13:191–202.
3. Jones DT, Monroy D, Ji Z, et al. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994; 35:3493–504.
4. Pflugfelder SC, Huang AJ, Feuer W, et al. Conjunctival cytologic features of primary Sjögren's syndrome. Ophthalmology. 1990; 97:985–91.
5. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999; 19:201–11.
Article
6. Gulati A, Sacchetti M, Bonini S, Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol. 2006; 124:710–6.
Article
7. Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000; 41:1703–9.
8. Pflugfelder SC, Farley W, Luo L, et al. Matrix metallo proteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol. 2005; 166:61–71.
9. Corrales RM, Stern ME, De Paiva CS, et al. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci. 2006; 47:3293–302.
Article
10. Behrens A, Doyle JJMPH, Stern L, et al. Dysfunctional tear syndrome. A Delphi approach to treatment recommendations. Cornea. 2006; 25:900–7.
11. Management and therapy of dry eye disease: Report of the management and therapy subcommittee of the International dry eye workshop (2007). Ocul Surf. 2007; 5:163–78.
12. Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009; 147:198–205.
Article
13. De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated interferone-gamma. Invest Ophthalmol Vis Sci. 2007; 48:2553–60.
14. Ogawa N, Kawanami T, Shimoyama K, et al. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome. Clin Immunol. 2004; 112:235–8.
15. Petkovic V, Moghini C, Paoletti S, et al. I-TAC/CXCL11 is a natural antagonist for CCR5. J Leukoc Biol. 2004; 76:701–8.
Article
16. Yoon KC, De Paiva CS, Qi H, et al. Expression of Th-1 Chemokines and Chemokine Receptors on the Ocular Surface of C57BL/6 Mice: Effects of Desiccating Stress. Invest Ophthalmol Vis Sci. 2007; 48:2561–9.
Article
17. Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007; 144:86–92.
Article
18. Yoon KC, Im SK, Park YG, et al. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006; 25:268–72.
Article
19. Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant. 2007; 39:231–5.
Article
20. Yoon KC, Im SK, Seo MS. Changes of tear film and ocular surface in diabetes mellitus. Korean J Ophthalmol. 2004; 18:168–74.
Article
21. Kim HG, You IC, Yoon KC. I-TAC concentration in tears of dry eye patients and its correlation with tear surface parameters. J Korean Ophthalmol Soc. 2008; 49:1565–71.
Article
22. Sherry B, Tekamp-Olson P, Gallegos C, et al. Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1β. J Exp Med. 1988; 168:2251–9.
23. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002; 13:455–81.
Article
24. Kim JH, Kim HY, Ryu YH, et al. The effect of an anti-oxidative and anti-inflammatory functional dietary supplement in dry eye syndrome. J Korean Ophthalmol Soc. 2008; 49:1397–1405.
Article
25. Malesiń ski R, Bakunowicz-Ł azarczyk A, Wysocka J. The role of chemokines CCL3/ MIP-1 alfa and CCL4/ MIP-1 beta in pathogenesis of dry eye syndrome. Klin Oczna. 2008; 110–9:277–9.
26. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci. 2002; 43:2609–14.
27. Pflugfelder SC, de Paiva CS, Li D-Q, Stern ME. Epithelial-immune interaction in dry eye. Cornea. 2008; 27:S9–11.
28. Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T-cell mediated Ső gren's syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006; 176:3950–7.